HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles

por Sammons, Sarah L., Topping, Donna L., Blackwell, Kimberly L.
Publicado 2017

OTHR-10. Diverse survival outcomes of HER2+ Breast Cancer Brain Metastases (BrCBM) presenting with isolated brain relapse compared to those with concurrent extracranial disease

por Noteware, Laura, Ramirez, Luis, Alder, Laura, Dalal, Nicole, Herndon, James E, Floyd, Scott R, Van Swearingen, Amanda E D, Anders, Carey K, Sammons, Sarah L
Publicado 2021